Barinthus Biotherapeutics (BRNS) EBT (2020 - 2025)
Historic EBT for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to -$14.6 million.
- Barinthus Biotherapeutics' EBT fell 8005.41% to -$14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$76.1 million, marking a year-over-year decrease of 2946.77%. This contributed to the annual value of -$61.2 million for FY2024, which is 1998.77% up from last year.
- According to the latest figures from Q3 2025, Barinthus Biotherapeutics' EBT is -$14.6 million, which was down 8005.41% from -$21.2 million recorded in Q2 2025.
- Over the past 5 years, Barinthus Biotherapeutics' EBT peaked at $14.8 million during Q2 2022, and registered a low of -$25.0 million during Q2 2023.
- In the last 5 years, Barinthus Biotherapeutics' EBT had a median value of -$16.7 million in 2021 and averaged -$12.6 million.
- Its EBT has fluctuated over the past 5 years, first soared by 23632.59% in 2022, then crashed by 119520.75% in 2023.
- Quarter analysis of 5 years shows Barinthus Biotherapeutics' EBT stood at -$16.7 million in 2021, then tumbled by 38.93% to -$23.2 million in 2022, then rose by 21.88% to -$18.1 million in 2023, then dropped by 13.68% to -$20.6 million in 2024, then rose by 28.88% to -$14.6 million in 2025.
- Its EBT was -$14.6 million in Q3 2025, compared to -$21.2 million in Q2 2025 and -$19.7 million in Q1 2025.